We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MRK market cap is 258.15B. The company's latest EPS is USD 0.1443 and P/E is 706.86.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 15.96B | 14.63B | 15.78B | 16.11B | 16.66B |
Operating Income | 5.75B | -1.97B | 5.64B | 6.05B | 3.93B |
Net Income | 4.75B | -1.23B | 4.76B | 5.46B | 3.16B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 46.84B | 47.99B | 48.7B | 59.28B | 60.12B |
Operating Income | 11.6B | 7.91B | 12.54B | 17.95B | 2.36B |
Net Income | 9.71B | 7.07B | 13.05B | 14.52B | 365M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 106.73B | 106.68B | 105.85B | 112.63B | 117.53B |
Total Liabilities | 65.43B | 69.04B | 65.43B | 68.98B | 72.97B |
Total Equity | 41.3B | 37.64B | 40.42B | 43.65B | 44.56B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 84.4B | 91.59B | 105.69B | 109.16B | 106.68B |
Total Liabilities | 58.4B | 66.18B | 67.44B | 63.1B | 69.04B |
Total Equity | 26B | 25.4B | 38.26B | 46.06B | 37.64B |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 12.76B | 13.01B | 3.09B | 8.73B | 18.02B |
Investing | -14.14B | -14.08B | -1.38B | -2.45B | -6.29B |
Financing | -2.57B | -4.81B | -2.81B | -1.6B | -4.02B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 13.44B | 10.25B | 14.11B | 19.1B | 13.01B |
Investing | -2.63B | -9.44B | -16.56B | -4.96B | -14.08B |
Financing | -8.86B | -2.83B | 2.59B | -9.12B | -4.81B |
Market Cap | 258.15B |
Price to Earnings Ratio | 706.86 |
Price to Sales Ratio | 4.29 |
Price to Cash Ratio | 37.72 |
Price to Book Ratio | 6.86 |
Dividend Yield | 3.17% |
Shares Outstanding | 2.53B |
Average Volume (1 week) | 14.63M |
Average Volume (1 Month) | 13.99M |
52 Week Change | -2.02% |
52 Week High | 134.63 |
52 Week Low | 94.48 |
Spread (Intraday) | 1.1 (1.07%) |
Company Name | Merck and Co Inc |
Address |
820 bear tavern road west trenton, new jersey 08628 1021 |
Website | https://www.merck.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions